All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
LevFinLevFin Leveraged Loans

Ethypharm tightens pricing on buyout debt

Pills_230px

Ethypharm, the French pharmaceutical firm, has allocated a €337m seven year term loan ‘B’ at tighter pricing than initial guidance, following a heavy oversubscription.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree